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Although mood stabilisers have substantially improved the treatment of bipolar disorder, recent studies
suggest that treatment with lithium is not as effective as originally claimed. Furthermore, patients still have
high rates of relapse even when prescribed medication. Recent research has shown that poor coping strategies
in response to bipolar prodromes and disruptions of sleep and social routines increase the risk of relapse.
Combining a psychosocial approach with medication may improve the rate of relapse prevention. Cognitive
therapy teaches patients better self-monitoring and coping skills and is therefore an appropriate means of
minimising psychosocial risk factors for relapse. Recent randomised controlled trials suggest that combined
medication and cognitive therapy significantly reduce bipolar relapse compared with medication alone.
Abstract
Bipolar illness is a severe and often very disabling
disorder. Although the prognosis can be good,
bipolar disorder may be associated with poor social
functioning (Bauwens et al, 1991), reduced rates of
employment (Prien & Potter, 1990), high levels
of substance misuse and elevated risk of suicide.
Chen & Dilsaver (1996) reported a lifetime rate of
suicide attempts in those with bipolar disorder of
30%, compared with 16% in those with unipolar
depression and 4% in those with other Axis I
disorders, as defined by the DSM–IV criteria
(American Psychiatric Association, 1994a).
Bipolar affective disorder has a prevalence of
about 1.0–1.5% in the adult population, with first
onset typically occurring in early adulthood. There
seem to be similar rates of prevalence for men and
women and there is little evidence that marital status
or geographical location influence prevalence,
although some studies suggest that bipolar disorder
occurs more often in middle and upper social groups.
Relapse and recurrence
of bipolar disorder
For many patients, the prognosis of bipolar disorder
is not good, as the disorder is associated with fre-
quent relapses and recurrences (Keller et al, 1993;
Winokur et al, 1993). Tohen et al (1990) reported that
after follow-up over 4 years, nearly 90% of a sample
of 75 patients with bipolar disorder had experienced
at least one relapse after remission of the index
episode. When clinical criteria are used, it is esti-
mated that, on average over a lifetime, a patient with
bipolar I disorder will experience 8–12 episodes of
depression and 4–8 episodes of mania. These high
rates of relapse and recurrence indicate that treat-
ment in bipolar disorder should focus on effective
reduction of acute symptoms during a bipolar
episode (depression or mania) and effective relapse
prevention. Likewise, for each patient, factors that
might influence relapse need to be examined system-
atically. Psychosocial factors related to relapse and
recurrence are highlighted below.
Pharmacological treatment
of bipolar illness
Medication has been the predominant treatment for
bipolar disorder, with lithium carbonate the
treatment of choice for three decades. This  reflects
the prevailing view that bipolar depression is
biological in origin, consistent with the evidence of
a strong genetic component to the disorder. Lithium,
carbamazepine and sodium valproate are used as
mood stabilisers, with the intention of treating the
acute episodes of mania and depression and pre-
venting relapse and recurrence. In addition, neuro-
leptics such as chlorpromazine and haloperidol are
often prescribed for treatment of acute manic
episodes. Similarly, antidepressants are often pre-
scribed for treatment of episodes of acute depression.
Treatment of acute episodes
There is good evidence that lithium is efficacious in
the treatment of the acute phase of mania, although
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the addition of major tranquillisers may be clinically
indicated for more severely ill patients (American
Psychiatric Association, 1994b). Although less
stringently evaluated than lithium, the current
evidence suggests that carbamazepine and valproate
have equivalent efficacy to lithium in the treatment
of manic episodes. Research on pharmacotherapy
for acute bipolar depression is less common and
harder to interpret because of methodological
difficulties (Prien & Potter, 1990).
Relapse prevention
What about the prevention of relapse and recur-
rence? How well do mood stabilisers prevent further
bipolar episodes? Studies in the 1960s and 1970s
suggested that lithium was an effective form of
prophylaxis. However, reviews of more recent
randomised controlled double-blind trials of mood
stabilisers have suggested that these medications
are not as effective at preventing relapse as initially
reported (Moncrieff, 1995; Solomon et al, 1995;
Silverstone et al, 1998). Whereas the original studies
in the 1960s reported that patients on lithium
experienced relapse rates of 35% over 2 years, more
recent studies find average relapse rates of 50%
over a 2-year follow-up. Furthermore, a significant
proportion of patients with bipolar disorder do not
seem to benefit from mood stabiliser medication.
Prien & Potter (1990) estimated that lithium was
ineffective in up to 20–40% of cases, either because
of inadequate response or poor compliance due to
the side-effects of medication. Although further
research trials are required to enable a reliable
determination of the degree of efficacy for other
medications such as carbamazepine and valproate,
their efficacy appears to be similar to that of lithium.
Several particular subtypes of bipolar depression
have been identified as being less responsive to
lithium. The rapid-cycling subtype, that is, having
four or more mood episodes per year, seems to be
less responsive to lithium treatment. Similarly, mixed
affective state, that is, the simultaneous occurrence
of both manic and depressed symptoms, is a pre-
dictor of poor response to lithium. Patients with
bipolar disorder with comorbid personality dis-
orders or high levels of neuroticism have also been
found to respond poorly to the medication. Patients
with higher numbers of previous episodes are also
less responsive to lithium treatment. It is still an open
question whether the factors that predict poor
response to lithium treatment are specific predictors
of poor prognosis to this particular medication or
general predictors of a poor response to any treat-
ment. If bipolar disorder has any similarities to
unipolar depression, some of these factors might be
expected to predict poor response to any treatment,
in the same way that chronicity of depression and
number of previous episodes in unipolar depression
predict poor outcome for both pharmacotherapy and
psychotherapy.
It is worth noting that combined medication
(e.g. Calabrese et al, 1992; Denicoff et al, 1997; Frye
et al, 2000), i.e. lithium plus other mood stabilisers
such as carbamazepine or valproate, appears to be
superior to monotherapy in achieving prophylaxis.
Reduced relapse for adjunctive medication on top
of lithium points to a biological basis for the improve-
ment in outcome, consistent with the view that the
origins of bipolar depression are biological. None-
theless, there are still relatively high rates of relapse
in those on combined medication. For example,
Denicoff et al (1997) reported that combined lithium
and carbamazepine had some success in only 50%
of patients with rapid-cycling bipolar disorder.
Thus, although pharmacotherapy for bipolar
disorder has produced significant benefits both in
the treatment of acute episodes and in relapse pre-
vention, there are still high rates of relapse and a
clear need for the development of improved treatment
approaches for bipolar disorder.
Psychosocial approaches
to bipolar illness
Given that structured psychological treatments such
as cognitive therapy have been found to be effective
in both the acute treatment and relapse/recurrence
prevention of unipolar depression, it is possible that
a cognitive therapy approach would reduce rates of
relapse in bipolar disorder. Therapies based on
teaching patients new coping skills, as is done in
cognitive therapy (see, e.g. Williams & Garland,
2002), may be particularly appropriate for bipolar
disorder, given recent evidence that particular
coping skills and behavioural responses are
important in the course of bipolar illness.
Bipolar prodromes
Prodromes are the early signs and symptoms that
can precede a full-blown episode. Recent research
has suggested that there are common prodromes for
both mania and depression and that patients with
bipolar disorder can reliably identify their pro-
dromes (Molnar et al, 1988; Smith & Tarrier, 1992;
Lam & Wong, 1997; Boxes 1 and 2). It is worth noting
that patients find it easier to recognise prodromes
for mania than for depression, possibly because
the onset of mania is often more acute and more
dramatic, whereas bipolar depression seems to
develop more insidiously. There appears to be a
relationship between residual symptoms and
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prodromal symptoms (Fava, 1999) which, given that
residual symptoms predict future outcome in
depression, further indicates the value of identifying
and intervening at the level of these symptoms
(e.g. Fava et al, 1998).
Importantly, patients with bipolar disorder dis-
play different coping strategies to deal with their
prodromes, with the type of coping approaches
chosen in response to manic prodromes predicting
the level of social functioning and number of relapses
18 months later (Lam et al, 2001). In general, helpful
coping strategies involve behavioural activities that
act against the prevailing prodrome, whereas un-
helpful coping strategies further reinforce the initial
stages of the bipolar episode, fuelling more-extreme
mood swings. Thus, for mania prodromes, engaging
in calming activities, increasing rest, reducing
stimulation and decreasing activity would be useful
strategies, whereas increasing activity levels, enjoy-
ing the ‘high’, and ‘making up for lost time’ would
be unhelpful strategies likely to increase the risk of
a full-blown manic episode. Similarly, for depression
prodromes, keeping busy and maintaining routines
are associated with better outcomes, whereas cutting
down on activities, withdrawing from other people
and going to bed are associated with worse out-
comes. For both manic and depressed prodromes,
seeing a doctor and increasing the appropriate
medication are also useful coping strategies.
Each patient will have his or her own idiosyncratic
prodromes so, clinically, it is advantageous to review
the weeks preceding each distinct bipolar episode
to determine the signs and symptoms that occur as
the episode develops. Separating the prodromes into
early, middle and late signs is a useful way of struc-
turing the chronology of an episode’s development,
with late signs reflecting the symptoms of the full-
blown episode and early signs reflecting the earliest
possible indication of a change in mood state. For
example, for one patient, an increase in witticisms
and puns may be an early sign of an impending
manic episode, while for another it may be that
colours appear sharper and more vivid. Because a
number of prodromes occur in a social context,
involving friends and families in their identification
and monitoring can be very productive. The research
evidence suggests that helping patients with bipolar
disorder to identify their prodromes and teaching
them straightforward responses to counteract them
can be beneficial in reducing the risk of relapse. Since
the prodromes for mania can precede a full bipolar
syndrome by several weeks (Molnar et al, 1988; Smith
& Tarrier, 1992) early detection followed by effective
coping strategies can be very helpful in ‘nipping an
episode in the bud’.
Life events and routine
There is evidence that life events and routine play
an important role in the period prior to the onset of
a bipolar episode. Malkoff-Schwartz et al (1998)
reported that in the 8 weeks prior to manic episodes,
a significantly greater proportion of patients had
experienced events that disrupted social rhythm
than in an 8-week episode-free control period. Such
events involve changes to daily or social routine, in
particular disruptions of sleep or changes in
working schedule. Disruptions to circadian rhythms
have been implicated in the onset of bipolar episodes
(Wehr et al, 1983; Healy & Williams, 1989), and there
are reports of patients who relapsed after long-
distance travel or jet lag (Jauhar & Weller, 1982). The
American Psychiatric Association (1994b) recom-
mends regular social and sleep routines within their
treatment guidelines for bipolar illness.
Modifying cognitive therapy
for bipolar disorder
The psychosocial literature reviewed above suggests
that helping patients with bipolar disorder to moni-
tor their prodromes, develop new coping strategies
and improve their daily routine, as well as using
appropriate psychotropic medication, would help
to reduce their risk of relapse. Structured, short-term,
problem-focused therapies such as cognitive therapy
are particularly suited to developing these skills.
Cognitive therapy is built on the view that thinking,
mood and behaviour all have a reciprocal influence
on each other. Therapists aim to teach patients to
become more aware of their thoughts and behaviours
Box 1 Common prodromes of mania







Box 2 Common prodromes of depression
Reduced interest in people or activities
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and to then alter dysfunctional thoughts and
behaviours. For example, in cognitive therapy for
depression, patients are taught to challenge their
self-critical thoughts such as ‘I am a failure’ by look-
ing for evidence and alternative explanations that
do not fit the negative interpretations (Box 3). Simi-
larly, patients with depression are encouraged to
increase their levels of pleasurable and achievement-
related activities, have more structured routines and
reduce unhelpful patterns of behaviour such as
social withdrawal and avoidance. This combination
of monitoring and behavioural change is comple-
mentary to the psychosocial research on prodromes
and routine in patients with bipolar disorder,
indicating that cognitive therapy may be a useful
approach in such cases.
Attempts to develop cognitive–behavioural
approaches for bipolar disorder have been based
within a diathesis–stress model. This approach
proposes that there is an inherent biological vulner-
ability in bipolar illness, as a function of instability
of circadian rhythms and of impaired regulation of
the motivational system controlling approach and
reward (Depue & Iacono, 1989). It is proposed that
disruption of sleep and routine can lead to dysregu-
lation of circadian rhythms and the motivational
system, leading to prodromal symptoms. The exact
nature of life events and social disruptions may
determine the specific prodromal symptoms that
occur. For example, events involving goal attainment
are associated with the development of manic
symptoms (Johnson et al, 2000a), whereas negative
life events, low social support and low self-esteem
predict the development of depressive symptoms
(Johnson et al, 2000b). The cognitive–behavioural
approach to bipolar disorder then predicts that the
particular coping strategies adopted in response to
prodromal symptoms will determine whether a full
bipolar episode will occur, which is more likely if
coping strategies are poor. Finally, the consequences
of a bipolar episode may further contribute to the
maintenance of the episode. For example, impulsive
spending may lead to financial problems; irritability
coupled with poor concentration may lead to
problems at work or the loss of employment; and
promiscuous behaviour may lead to problems in
intimate relationships. All of these episode-related
difficulties could then act as further stressors to
interact with the underlying biological vulnerability,
to further generate bipolar symptoms.
The recognition of a biological vulnerability
within the cognitive–behavioural approach to
bipolar disorder, coupled with the identified need
to improve relapse prevention, means that cognitive
therapy for bipolar disorder has been conceptualised
only as an adjunct to medication rather than as a
replacement for it. Furthermore, cognitive therapy
has been designed as a relapse prevention treatment,
not as an acute treatment. Thus, attempts to modify
cognitive therapy for bipolar disorder have concen-
trated on working with patients with the illness in a
relatively euthymic state, outside of a major
depression or manic episode. Clinical experience
suggests that attempting cognitive therapy with
patients with bipolar disorder who are in a manic
episode is difficult and unlikely to be effective. There-
fore, for maximum benefit, the cognitive therapy
approach needs to be applied when patients are in
remission between episodes.
To date, there have been several attempts to
examine the efficacy of adding cognitive therapy
to medication for bipolar disorder. Lam et al (2000)
and Scott et al (2001) have reported that the addition
of cognitive therapy to routine mood stabilisers
produced significantly reduced relapse compared
with routine mood stabilisers alone. However, both
of these were pilot studies with small samples, such
that any conclusions from them need to be tentative.
Fava et al (2001) reported that cognitive–behavioural
therapy reduced residual symptoms in patients with
bipolar disorder who relapsed on lithium and may
improve lithium prophylaxis. However, this study
had a small sample size (n=15) and there was no
comparison treatment group such as treatment as
usual. In a randomised controlled trial, Perry et al
(1999) taught patients with bipolar disorder to detect
early warning signs and seek medical help earlier
than those on treatment as usual. Although not a
trial of a full cognitive therapy package, this study
did demonstrate that teaching improved monitoring
and better coping skills could significantly reduce
bipolar relapse. Zaretsky et al (1999) found that
cognitive therapy could be helpful in treating epi-
sodes of bipolar depression, although this study was
also limited by having only a small sample.
More recently, a full-scale randomised controlled
trial of cognitive therapy for bipolar disorder has
been completed (Lam et al, 2003). This study investi-
gated the efficacy of cognitive therapy in conjunction
with routine mood stabilisers in the prevention of
Box 3 Outline of cognitive therapy for
depression
Assessment of current symptoms and problems
Psychoeducation that thoughts, feelings and
behaviours influence each other
Scheduling of increased pleasurable and
achievement activities
Teaching patients to identify and challenge
negative thoughts
Identifying and challenging dysfunctional
assumptions that maintain depression
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bipolar episodes over a 12-month period. It recruited
103 patients with bipolar I disorder, who were being
prescribed prophylactic medication at a rec-
ommended dose and who were not currently in an
acute bipolar episode. To ensure that the patients
treated were a group that was highly vulnerable
to relapse/recurrence despite the provision of
adequate levels of mood stabilisers, all those
included in the trial had to have experienced at least
two bipolar episodes in the previous 2 years or three
episodes in the previous 5 years.
Patients were randomly allocated either to a
treatment-as-usual group or to a combined medi-
cation and cognitive therapy group. The treatment-
as-usual group received mood stabilisers at a
recommended level with regular psychiatric follow-
up as out-patients. The combined medication and
cognitive therapy group received treatment as usual
plus cognitive therapy.
The cognitive therapy was based on a previously
developed treatment manual (Lam et al, 1999) and
consisted of 12–18 weekly sessions, followed by
2 booster sessions each after 3-month intervals. The
cognitive therapy package was developed from the
classic cognitive therapy approach for depression
(Beck et al, 1979), adapted to take into account
psychosocial research into bipolar disorder (Box 4).
Teaching better coping responses to prodromes is
one core element of cognitive therapy for bipolar
disorder. Identifying and challenging dysfunctional
thoughts and beliefs is another. Depression-related
thoughts and beliefs are challenged as per the
standard cognitive therapy for unipolar depression.
In addition to challenging negative thoughts,
patients can challenge dysfunctional positive
thoughts associated with mania. For example, indivi-
duals can be taught to examine grandiose thoughts
such as  ‘I know better than everyone else’ and check
whether these accurately reflect their past experience
and whether such thoughts are dependent on their
mood. Similarly, patients can be encouraged to
examine the longer-term costs and benefits of their
more-impulsive thoughts (e.g. ‘I need to buy that
now’), to prevent overimpulsive behaviour. Patients
can also be encouraged to examine grandiose and
impulsive plans across a longer time frame (‘How
many of your ideas still seem good a week later? If
this is genuinely a good idea, it should still be a
good idea next week. Can you try to leave it for a
week?’). Highly driven and extreme goal-attainment
beliefs, e.g. ‘I should be happy all the time’, ‘If I put
in enough effort, I should be able to achieve
everything I want’ are hypothesised to be vulner-
ability factors for mania. Patients with bipolar
disorder who have these attitudes are more likely to
engage in extreme goal-pursuing behaviour likely
to disrupt their sleep and daily routines, precipi-
tating further episodes. Cognitive therapy can
involve identifying such beliefs in collaboration with
patients and then exploring how realistic and useful
these beliefs are.
Overall, Lam et al (2003) found that, at 12 months,
the combined medication and cognitive therapy
group had significantly fewer bipolar episodes
compared with the treatment-as-usual group
(cumulative relapse 44% v. 75%), fewer days in
bipolar episodes (27 v. 88) and significantly fewer
hospitalisations. Those in the combined medication
and cognitive therapy group were also significantly
better than the treatment-as-usual group at coping
with mania prodromes at 12 months, although there
was no significant difference between the groups in
coping with depression prodromes.
One area that requires future research concerns
the impact of cognitive therapy on medication
compliance. After 6 months, a significantly greater
proportion of patients in the combined medication
and cognitive therapy group (88%) than in the
treatment-as-usual group (67%) reported missing
their medication fewer than three times in the
previous month. However, serum levels were avail-
able for only 50% of the sample, limiting the power
of any calculation to test whether differences in
compliance were reflected in serum levels. Never
the less, more patients in the combined medication
and cognitive therapy group (93%) met the criterion
of an adequate serum level of mood stabilisers than
in the treatment-as-usual group (78%). At this stage,
it is not possible to tell to what degree cognitive
therapy reduced bipolar relapse simply by improv-
ing compliance with mood stabiliser medication or
by other mechanisms such as improving coping
skills.
The principal limitation of the Lam et al (2003)
study was that there was no control treatment for
the increased level of face-to-face contact that the
cognitive therapy patients received compared with
Box 4 Additions to cognitive therapy for
bipolar disorder
Psychoeducation explaining the diathesis–
stress model, outlining the joint role of
medication and psychological treatment
Teaching self-monitoring and self-regulation
skills, with an emphasis on identification of
prodromes and development of good coping
strategies
Promoting the importance of sleep and routine
Therapists gently challenge excessively positive
thoughts
Therapists try to reduce the patient’s over-
striving behaviour and attitudes
Cognitive therapy plus medication in bipolar disorder
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the treatment-as-usual group. Therefore, it is not
possible to determine whether the improved
outcome was due to specific aspects of cognitive
therapy or due to non-specific therapy effects such
as increased attention and support. Nonetheless,
the study demonstrated that the addition of
cognitive therapy to medication for bipolar disorder
has benefits in reducing the frequency and durations
of relapse/recurrence and in reducing the extent of
hospitalisation.
Conclusions
Bipolar disorder is a relatively common and severe
condition. Although the use of medication has
produced substantial treatment benefits, particularly
in the treatment of acute episodes, a substantial
proportion of patients with bipolar disorder still
relapse despite the use of mood stabilisers. Poor
coping strategies in response to prodromes and
disruptions of sleep and social routine have been
implicated in bipolar relapse. Cognitive therapy is
well suited to teach patients better coping strategies
to deal with prodromes and stressors and thereby
to minimise their risk of relapse. Pilot studies and
one large-scale randomised controlled trial have
found that the addition of cognitive therapy to
routine mood stabilisers significantly reduces the
number of bipolar episodes over a 1-year period.
Although further large-scale trials with longer
follow-ups are required to confirm these findings,
the current evidence indicates that the addition of
cognitive therapy to medication substantially
improves the treatment of bipolar disorder. In
clinical practice, helping patients to identify and
respond effectively to their prodromes may help to
reduce the risk of relapse.
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Multiple choice questions
1 Over a lifetime, on average, a patient with bipolar
disorder will experience:
a 0–4 episodes of depression and 0–2 episodes of mania
b 4–8 episodes of depression and 0–4 episodes of mania
c 4–8 episodes of depression and 8–10 episodes of mania
d 8–12 episodes of depression and 4–8 episodes of mania
e 12–16 episodes of depression and 10–12 episodes of
mania.
2 More-recent studies suggest that, with lithium, the







1 2 3 4 5
a F a F a F a T a T
b F b F b T b F b T
c F c F c T c T c F
d T d T d F d F d T
e F e F e T e T e T
3 Known factors that predict lower response to lithium
in bipolar disorder include:
a a recent severe life event
b comorbid personality disorder
c mixed affective states
d gender of the patient
e rapid-cycling bipolar disorder.
4 Common prodromes for mania include:
a reduced need for sleep
b increased worry
c racing thoughts
d withdrawal from people
e increased goal-directed activity.
5 Lam et al found that, compared with medication
alone, the addition of cognitive therapy to medi-
cation for bipolar disorder:
a reduced bipolar relapses over 1 year
b improved compliance with medication
c improved coping with depression prodromes
d reduced hospitalisation
e improved coping with mania prodromes.
